tiprankstipranks
Trending News
More News >
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
US Market

Marker Therapeutics (MRKR) Financial Statements

Compare
598 Followers

Marker Therapeutics Financial Overview

Marker Therapeutics's market cap is currently $30.51M. The company's EPS TTM is $-0.12; its P/E ratio is -1.39; Marker Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 6.59M$ 3.31M$ 3.51M$ 1.24M$ 466.79K
Gross Profit$ -6.88M$ -7.11M$ -8.45M$ -1.92M$ -18.41M
Operating Income$ -11.12M$ -14.58M$ -19.79M$ -39.48M$ -28.89M
EBITDA$ -11.12M$ -11.79M$ -17.00M$ -38.72M$ -27.63M
Net Income$ -10.73M$ -8.24M$ -29.93M$ -41.88M$ -28.71M
Balance Sheet
Cash & Short-Term Investments$ 19.19M$ 15.11M$ 11.78M$ 42.35M$ 21.35M
Total Assets$ 22.02M$ 17.13M$ 34.42M$ 68.14M$ 45.61M
Total Debt$ 0.00$ 0.00$ 7.62M$ 11.87M$ 12.26M
Net Debt$ -19.19M$ -15.11M$ -4.17M$ -30.48M$ -9.10M
Total Liabilities$ 3.46M$ 3.07M$ 14.82M$ 24.15M$ 18.27M
Stockholders' Equity$ 18.56M$ 14.05M$ 19.60M$ 43.99M$ 27.34M
Cash Flow
Free Cash Flow$ -10.91M$ -16.44M$ -26.97M$ -30.41M$ -29.29M
Operating Cash Flow$ -10.91M$ -16.44M$ -26.97M$ -27.28M$ -20.03M
Investing Cash Flow$ 0.00$ 18.66M$ -4.95M$ -3.13M$ -9.25M
Financing Cash Flow$ 14.99M$ 1.11M$ 202.13K$ 52.56M$ 6.74M
Currency in USD

Marker Therapeutics Earnings and Revenue History

Marker Therapeutics Debt to Assets

Marker Therapeutics Cash Flow

Marker Therapeutics Forecast EPS vs Actual EPS